A high-performance microsystem for isolating circulating tumor cells.
暂无分享,去创建一个
Yitshak Zohar | Xiangjun Zheng | Y. Zohar | L. Cheung | Linan Jiang | J. Schroeder | Linan Jiang | Xiangjun Zheng | Luthur Siu-Lun Cheung | Joyce A Schroeder
[1] J. Witte,et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] T. Springer,et al. Neutrophils roll on E-selectin. , 1993, Journal of immunology.
[3] Kristine R Broglio,et al. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. , 2007, Clinical breast cancer.
[4] Mehmet Toner,et al. A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects. , 2007, Lab on a chip.
[5] Lap Man Lee,et al. Low melting point agarose as a protection layer in photolithographic patterning of aligned binary proteins. , 2006, Lab on a chip.
[6] Milica Radisic,et al. Microfluidic depletion of endothelial cells, smooth muscle cells, and fibroblasts from heterogeneous suspensions. , 2008, Lab on a chip.
[7] T. Yagi,et al. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. , 2000, Genes & development.
[8] Keith R. Johnson,et al. N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression , 1999, The Journal of cell biology.
[9] Xiangjun Zheng,et al. Kinematics of Specifically Captured Circulating Tumor Cells in Bio-Functionalized Microchannels , 2010, Journal of Microelectromechanical Systems.
[10] D. A. Hammer,et al. Receptor-mediated binding of IgE-sensitized rat basophilic leukemia cells to antigen-coated substrates under hydrodynamic flow. , 1994, Biophysical journal.
[11] Xiangjun Zheng,et al. Adhesion dynamics of circulating tumor cells under shear flow in a bio-functionalized microchannel , 2011 .
[12] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[13] D. Bostwick,et al. Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. , 1999, The Journal of urology.
[14] D. Altman,et al. Statistics Notes: Diagnostic tests 1: sensitivity and specificity , 1994 .
[15] C. Rubio,et al. The tumor-associated antigens BR55-2, GA73-3 and GICA 19-9 in normal and corresponding neoplastic human tissues, especially gastrointestinal tissues. , 1989, Anticancer Research.
[16] S. Troyanovsky,et al. Mechanism of cell-cell adhesion complex assembly. , 1999, Current opinion in cell biology.
[17] S. Braun,et al. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] Paul I. Okagbare,et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. , 2008, Journal of the American Chemical Society.
[19] M. Steurer,et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival , 2003, British Journal of Cancer.
[20] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[21] P. Robinson,et al. Increased expression of a 38kd cell-surface glycoprotein MH99 (KS 1/4) in oral mucosal dysplasias. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[22] D. Hammer,et al. Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow , 1995, Nature.
[23] B. Wollenberg,et al. Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. , 2003, Cancer letters.
[24] D. Hayes,et al. The measurement and therapeutic implications of circulating tumour cells in breast cancer , 2005, British Journal of Cancer.
[25] J. V. van Krieken,et al. Expression of Ep‐CAM in normal, regenerating, metaplastic, and neoplastic liver , 1999, The Journal of pathology.
[26] S. Litvinov,et al. The biology of the 17–1A antigen (Ep-CAM) , 1999, Journal of Molecular Medicine.
[27] Keith R. Johnson,et al. Cadherins as modulators of cellular phenotype. , 2003, Annual review of cell and developmental biology.
[28] Dorian Liepmann,et al. Biomimetic technique for adhesion-based collection and separation of cells in a microfluidic channel. , 2005, Lab on a chip.
[29] D. Hammer,et al. Simulation of cell rolling and adhesion on surfaces in shear flow: general results and analysis of selectin-mediated neutrophil adhesion. , 1992 .
[30] James C Baygents,et al. Detachment of captured cancer cells under flow acceleration in a bio-functionalized microchannel. , 2009, Lab on a chip.
[31] Y. Hannun,et al. EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy , 2004, Cancer Research.
[32] T. Fehm,et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells , 2009, Breast Cancer Research.
[33] S. Byers,et al. Cadherin-11 is expressed in invasive breast cancer cell lines. , 1999, Cancer research.
[34] N. Tran,et al. Signal Transduction from N-cadherin Increases Bcl-2 , 2002, The Journal of Biological Chemistry.
[35] J. Murray,et al. Monoclonal antibody therapy for solid tumors. , 2000, Cancer treatment reviews.
[36] Claire Holloway,et al. Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage , 2004, Breast Cancer Research and Treatment.
[37] B. Gumbiner,et al. Molecular and functional analysis of cadherin-based adherens junctions. , 1997, Annual review of cell and developmental biology.
[38] M. Peters,et al. Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines , 2005, British Journal of Cancer.